| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/28/1991 | EP0109439B1 Amino acid solutions for parenteral nutrition and methods of formulation and use |
| 08/28/1991 | CN1054065A Thiazine or oxazine derivatives and preparation thereof |
| 08/28/1991 | CA2053256A1 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives |
| 08/27/1991 | US5043457 2(5H)-furanones substituted in the 3 position, as Ca2+ channel antagonists and anti-inflammatory agents |
| 08/27/1991 | US5043353 A80789 polyether antibiotic |
| 08/27/1991 | US5043330 Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/27/1991 | US5043323 Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them |
| 08/27/1991 | US5043273 Phosphorylated glycosidase inhibitor prodrugs |
| 08/27/1991 | CA2036417A1 Quinoline and pyridine anchors for hmg-coa reductase inhibitors |
| 08/24/1991 | CA2036902A1 Hypoglycemic agents |
| 08/22/1991 | WO1991012817A1 Novel insulin compositions |
| 08/22/1991 | WO1991012239A1 HOMOLOGATED VITAMIN D2 COMPOUNDS AND THE CORRESPONDING 1α-HYDROXYLATED DERIVATIVES |
| 08/22/1991 | WO1991012235A1 Allosteric hemoglobin modifiers |
| 08/22/1991 | WO1991011918A1 Docosahexaenoic acid, methods for its production and compounds containing the same |
| 08/22/1991 | CA2075982A1 Insulin compositions |
| 08/21/1991 | EP0442140A1 Dietetic food for patients with renal insufficiency |
| 08/21/1991 | EP0441889A1 Modified human growth hormone |
| 08/20/1991 | WO1991012265A1 N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them |
| 08/20/1991 | US5041639 Polysubstituted derivatives of naphtalene, their process of preparation and their application in the cosmetic and pharmaceutical fields |
| 08/20/1991 | US5041544 Method of manufacturing moranoline derivatives |
| 08/20/1991 | US5041451 Analgesics, hypotensive agents |
| 08/20/1991 | US5041444 Hypoglycemic agents; anticoagulants |
| 08/20/1991 | US5041441 Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol |
| 08/20/1991 | CA2069087A1 N-phenyl n-alcoxycarbonylalkylglycinamides, their preparation and medicaments containing them |
| 08/14/1991 | EP0441539A2 Thiazine (or oxazine) derivatives and preparation thereof |
| 08/14/1991 | EP0440809A1 Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient |
| 08/14/1991 | EP0440626A1 Synthetic gtf chromium material and process therefor |
| 08/14/1991 | CN1053744A Modified release gemfibrozil composition |
| 08/14/1991 | CA2035980A1 Pharmaceutical compositions |
| 08/13/1991 | US5039700 Cardiovascular disorders, antitumor agents |
| 08/13/1991 | US5039698 Method for weight reduction |
| 08/13/1991 | US5039672 Administering enzyme inhibitors to control diabetes |
| 08/13/1991 | US5039609 low molecular weight peptides in aqueous solution; from enzymatic hydrolysis of proteins, purity, controlled concentration |
| 08/13/1991 | CA2035594A1 Use of retinoids to minimize skin damage |
| 08/13/1991 | CA1287639C Process for the lactonization of mevinic acids and analogs thereof |
| 08/13/1991 | CA1287629C Thiolactam-n-acetic acid derivatives, their production and use |
| 08/13/1991 | CA1287577C Growth promoting compositions |
| 08/13/1991 | CA1287473C Aluminum hydroxide |
| 08/09/1991 | CA2035147A1 Thiazine (or oxazine) derivatives and preparation thereof |
| 08/08/1991 | WO1991011457A1 Glp-1 analogs useful for diabetes treatment |
| 08/08/1991 | WO1991011180A1 Method of treating cancer using structured lipids |
| 08/08/1991 | CA2074492A1 Method of treating cancer using structure lipids |
| 08/07/1991 | EP0440347A1 Essential fatty acid compositions for increasing the fat content of mammalian milk |
| 08/07/1991 | EP0440333A2 Dopamine agonists for treating type II diabetes |
| 08/07/1991 | EP0440309A1 Pharmaceutical and dietary composition |
| 08/07/1991 | EP0440308A1 Pharmaceutical and dietary composition |
| 08/07/1991 | EP0440307A2 Pharmaceutical and dietary composition |
| 08/07/1991 | EP0440183A1 Oxazole compounds, their production and use |
| 08/07/1991 | CN1053613A Nitrogen-containing spirocycles |
| 08/07/1991 | CN1053606A Pyridine-2,4-and 2,5-di caboxylic acid =-(nitroxylalkyl) amide, process for preparing them and use |
| 08/07/1991 | CN1013444B Process for the preparation of a novel class of hypoglycemic agents |
| 08/06/1991 | US5037842 Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents |
| 08/06/1991 | US5037839 Hydroxylase enzyme inhibitors, influencing the metabolism of collagen and biosynthesis of c1q |
| 08/06/1991 | US5037831 Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
| 08/06/1991 | US5037817 Crystallization from polar or apolar solvents; produces two crystalline pure forms; improved stability increases shelf-life |
| 08/02/1991 | CA2035431A1 Oxazole compounds, their production and use |
| 07/31/1991 | EP0439321A2 Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use |
| 07/31/1991 | EP0439059A2 1-Phenylalkyl-3-phenylurea derivative |
| 07/31/1991 | EP0438921A1 Ganglioside derivatives and their use as medicaments |
| 07/31/1991 | EP0438795A1 Pyridine-2,4- and 2,5-dicarboxydi(nitroxyalkyl)amides, processes for their preparation, and their use |
| 07/31/1991 | EP0438483A1 Triglycerides and nutritional composition comprising such triglycerides. |
| 07/31/1991 | CN1013336B Method of preparation crystalline alpha-maltose |
| 07/31/1991 | CA2034174A1 Essential fatty acid compositions and treatments |
| 07/30/1991 | US5036080 (D)-6-fluoro-2,3-dihydro-2',5-dioxo-spiro[4H-1-benzopyran-4,4'-imidazolide]-2-carboxamide compounds |
| 07/30/1991 | US5036058 N-substituted aminoalkanediphosphonic acids |
| 07/30/1991 | CA1286990C Nutritional supplement for treatment of uremia |
| 07/27/1991 | WO1991011453A2 5-oxygenated-2,4,6-triaminopyrimidines |
| 07/27/1991 | CA2071000A1 5-oxygenated-2,4,6-triaminopyrimidines |
| 07/27/1991 | CA2034955A1 Dietary food for patients with renal insufficiency |
| 07/27/1991 | CA2032898A1 Method for treating cardiovascular diseases, e.g. myocardial ischemia and ventricular arrhythmia is enclosed |
| 07/25/1991 | WO1991010649A1 New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 07/25/1991 | WO1991010441A1 Polypeptide and amino acid based composition |
| 07/25/1991 | WO1991010369A1 Method for preparing an enzymatic hydrolyzate |
| 07/24/1991 | EP0438234A1 Antithrombin solution and use thereof |
| 07/24/1991 | EP0438147A2 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin |
| 07/24/1991 | EP0437524A1 Triglyceride and nutritional composition comprising such triglycerides. |
| 07/24/1991 | EP0437523A1 Triglycerides, nutritional composition comprising such triglycerides, and use of the nutritional composition for nutrition. |
| 07/24/1991 | EP0437522A1 Emulsion and use of the emulsion as a parenteral preparation |
| 07/24/1991 | EP0437521A1 Emulsion and use of the emulsion as a parenteral preparation |
| 07/24/1991 | EP0437520A1 Triglyceride and nutritional composition comprising such triglyceride. |
| 07/24/1991 | EP0437519A1 Triglycerides and nutritional composition comprising such triglycerides. |
| 07/24/1991 | EP0437518A1 Triglycerides and composition comprising such triglycerides. |
| 07/24/1991 | EP0231367B1 Use of oxirancarboxylic acids for the treatment of hyperlipemia |
| 07/24/1991 | CN1053230A Process for prepn. of ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 07/23/1991 | US5034414 Liquid emulsion for transfusion |
| 07/23/1991 | US5034399 Substituted 1,8-naphthyridines and their use in medicaments |
| 07/23/1991 | US5034398 1H-indazole-3-carboxamide-N-2-azabicyclo[2.2.2]octanes useful for treating anxiety, psychosis, neuralgia, migraine and cluster headaches |
| 07/23/1991 | US5034395 Hypotensive agents, carboxylated dihydropyridines |
| 07/23/1991 | CA2034673A1 1-phenylalkyl-3-phenylurea derivative |
| 07/23/1991 | CA2034616A1 Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use |
| 07/23/1991 | CA1286693C Cholecalciferol derivatives |
| 07/23/1991 | CA1286683C Hmg-coa reductase inhibitors |
| 07/23/1991 | CA1286681C Substituted 2-aminotetralins |
| 07/23/1991 | CA1286673C 1-phenoxy-propyl-4-¬n(phenyl)-thiocarbamoyl or carbamoyl|- trans-decahydroquinoline compounds |
| 07/23/1991 | CA1286671C Trans-6- 2-heteroaryl-3,5-disubstituted)pyrazol-4-yl)- ethyl) - or ethenyl) tetrahydro-4-hydroxypyran- 2-one inhibitors of cholesterol biosynthesis |
| 07/20/1991 | CA2034519A1 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin |
| 07/20/1991 | CA2033680A1 Administration method of antithrombin |
| 07/18/1991 | DE4001002A1 N'N'-di:(nitroxyalkyl) pyridine-2,4- and -2,5-di:carboxamide derivs. - used as proline and lysine hydroxylase inhibitors for use a immuno:suppressive, fibro-suppressive and collagen biosynthesis inhibitors |
| 07/17/1991 | EP0437367A2 Compositions and methods for inhibiting osteoclast cellular adhesion to bone |
| 07/17/1991 | EP0436911A2 Novel vitamin E derivatives and process for the production thereof |